Abstract: To increase the efficacy of atomizer nozzles operating with compressed gas, an atomizer device for inhalation therapy appliances includes means for delivering a compressed gas, in particular compressed air; means for supplying a fluid that is to be atomized, in particular a therapeutic liquid; several compressed gas outlet openings from which a delivered compressed gas emerges; and several fluid outlet openings from which the fluid to be atomized emerges on account of the emerging compressed gas. The atomizer device includes at least three compressed gas outlet openings arranged in a row, and one of the compressed gas outlet openings is in each case assigned at least two fluid outlet openings which, together with the associated compressed gas outlet opening, form an atomizer nozzle.

Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurized gas, preferably pressurized air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomized is therefore substantially atomized only in the inhalation phases.

Abstract: Aerosol therapy device comprising a nebuliser (10) for generating an aerosol and forming an aerosol flow, a first nosepiece (11) for introducing the aerosol flow into one of the two nostrils (12) of a user, a pressure fluctuation source for generating a pressure fluctuation (DS), a second nosepiece (14) for introducing the pressure fluctuation into the other of the two nostrils (15) of the user in order to superimpose the pressure fluctuation and the aerosol flow, and a sensor system comprising a first pressure sensor (19) for detecting the signal of the pressure fluctuation that arrives at the first nosepiece (11), and an evaluation means (18) that concludes the degree of closure of the velum of the user based on the signal.

Abstract: The inhalation therapy device comprises an aerosol generator (2) and a mixing chamber (3). The introduction of ambient air is achieved by means of supply channels (9) under the control of an inspiration valve (20), including an aerosol passage (22), a region with inspiration air through openings (23) and a valve element (21). The aerosol passage (22) surrounds the membrane (6) of the aerosol generator (2), whereby a front face edge (22a) of the tubular aerosol passage (22) lies along a sealing line (20a) on a surface of the aerosol generator (2).

Abstract: The invention describes a device and a method for cleaning an oscillatable membrane (3) of a membrane aerosol generator (4) of an inhalation therapy device, in which a cleaning liquid is supplied to the membrane (3) on the aerosol side, and the membrane (3) is caused to oscillate in such a manner that the cleaning liquid is conveyed through the openings of the membrane (3) to the liquid side of said membrane.

Abstract: In order to improve the wearing comfort and the sealing in an upper nasal region, the present invention proposes a face mask, in particular an inhalation mask for use with a therapeutic nebuliser, comprising a main mask body that comprises a first circumferential region, which is designed for the application of the mask to a user's face, and a second region for connection to, in particular, a therapeutic nebuliser, wherein a section of the first region is designed for application to an upper nasal region of the face and comprises two sealing lips connected in series. According to the invention, the two sealing lips connected in series are formed by a first inward-facing sealing lip and a second outward-facing sealing lip.

Abstract: For use in premature babies and infants, in particular for administering surfactant to the lungs, the inhalation therapy device described herein comprises an aerosol generating device 1, a respiratory air flow generating means 3 and a nebulising chamber 5 into which the generated liquid droplets 2 and the respiratory air flow 4 are supplied. The nebulising chamber 5 comprises a tapering area 52 which ends in a tubular intubation means 6. The intubation means 6 is designed such that the intubation end 6b can be positioned in such a manner that the liquid droplet/respiratory air mixture conveyed via the intubation means is released behind those areas of the respiratory tract that filter out to a great extent the liquid droplets from the mixture.

Abstract: The inhalation therapy device according to the invention comprises a nebulizer chamber which accommodates an aerosol generator that emits aerosol into the nebulizer chamber. A valve that has a valve seat, a resilient valve member and a valve member positioning means is arranged at an opening of the nebulizer chamber. The valve member positioning means can be moved out of a first position and into a second position so as to position the valve member on the valve seat in such a manner that in the first position, the valve member, in a flow-free state, is positioned on the valve seat in a pre-tensioned manner and in a second position, is spaced apart from the valve seat.

Abstract: The compressor comprises two compression spaces (1, 5) separate from one another, one of which serves to generate the continuous pressure medium flow for the generation of a basic aerosol flow, whereas the other is used to generate the pressure variations. The shared compression means (4), for example a piston, is moved in a pendulum motion by a drive (7) so that a gas is conveyed through the first compression space and pressure variations are imposed upon a gas volume via the second compression space. The drive is disposed in a compression space, use advantageously being made of the space volume available that may if necessary be made use of by the compressor. In a preferred embodiment the drive (7) is located in the compression space (5) that is used to generate the pressure variations.

Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nasal cavity or of the paranasal sinuses. The aerosol is characterised in that its pressure is not constant, but pulsates at a frequency of about 10 to 90 Hz. The mass median diameter of the dispersed phase is from about 2 to 6 ?m, and the volume of about 5 mL or less of the dispersed phase comprises a unit dose of an active compound. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.

Abstract: The invention describes an inhalation or breathing mask for therapeutic nebulisers, in which around a connecting socket 4 for the therapeutic nebuliser is arranged an exhalation valve consisting of exhalation openings and a flexible valve element. The exhalation openings 7 are formed by exhalation channels 8 and can be closed individually by closure devices, for example stoppers, in order to set a predefined exhalation resistance.

Abstract: The invention regards a therapeutic aerosol device in which a main aerosol flow, which is generated with the help of a compressed gas and is supplied to one of the nostrils of a user, is superimposed by pressure fluctuations. The superimposition of the pressure fluctuations occurs directly at one of the two nostrils of the user. A flow resistance is provided in the other nostril.

Abstract: The invention relates to a device for inhalation therapy. Said device comprises an aerosol-producing device for spraying a liquid (3), preferably comprising a membrane (1), a support unit (6), an electromechanical transducer unit (7), and a connecting device (8,9) for supplying an oscillation control signal. The inventive device also comprises a control device (10) from which an oscillation control signal can be supplied to the connecting device of the aerosol-producing device, such that the aerosol-producing device sprays the liquid. Another control signal is supplied to the aerosol-producing device (1,6,7), moving the membrane (1) in oscillation in an audible frequency range, thus causing the emission of audible signals for a user.

Abstract: The aim of the invention is to connect a nebulizer to a breathing air tube of a respirator. Said aim is achieved by a nebulizer-connecting device comprising a breathing air-directing unit that is provided with a first mechanism for connecting a duct supplying breathing air, a second mechanism for connecting a duct evacuating breathing air, and a third mechanism for connecting the nebulizer, and a sealing unit which is arranged on the third connecting mechanism and by means of which a flow path for an aerosol generated by the nebulizer can be unblocked when the nebulizer is connected while said flow path for an aerosol generated by the nebulizer can be sealed therewith when the nebulizer is removed. A sealing member is opened when the nebulizer is connected while being closed when the nebulizer is removed.

Abstract: The application describes a sterile aqueous inhalation solution containing the active agent tobramycin. The preparation has a high content of active agent (about 80 to 120 mg/ml of tobramycin) and contains an acidic adjuvant, but contains only a low concentration of sodium chloride (at most about 2 mg/ml). It can be injected or administered as an aerosol, for example with conventional nebuliser. It is particularly suitable for application in combination with a modern vibrating membrane nebuliser and allows the administration of a therapeutic single does in markedly less than 10 minutes.

Abstract: The invention relates to an inhalation therapy device with a nozzle nebuliser, in particular with a nozzle nebuliser having a nozzle element which is easy to clean and is thereby simple and reliable to handle so that the nozzle is not damaged and the geometry of the nozzle is not affected during cleaning. The aerosol generator comprises a nozzle element, said nozzle consisting of at least a first part and a second part, said first part of the nozzle element being made of a more resilient material than said second part of the nozzle element, and said first part of the nozzle element being attached to said second part of the nozzle element. Owing to the resilient material, the nozzle can deform during cleaning and can return to the original shape without altering its initial geometry.

Abstract: The invention describes an inhalation therapy device comprising a supply means 4 for a gaseous medium M, for example ventilation air of a ventilation device, and a flow influencing means 5, by means of which a sheath flow m is formed around an expansion area 2 for an aerosol generated by an aerosol generator 1 for therapeutic administration. Deposition of aerosol droplets or particles on the inner wall of the housing 9 of the inhalation therapy device is effectively prevented in this manner.

Abstract: The inhalation therapy device comprises a nebulising nozzle 1, to which compressed air 6 can be supplied for nebulising a liquid 5, a compressor 8 having an electromotive drive 8b for generating the compressed air supplied to the nebulising nozzle, and an electric energy store 9 for providing electric energy for the electromotive drive 8b of the compressor 8. The electric energy store 9 thereby comprises a stabilising device 9b that ensures a constant output voltage of the energy store 9.

Abstract: In an inhalation therapy apparatus a limiter section is provided in the air supply duct which serves as the limiting element for the movement of a valve element of an inlet valve. In the limiter section are provided openings through which surrounding air can flow when the valve element rests against the front edge of the limiter section facing the valve element.

Abstract: The present invention relates to an inhalation therapy device having a control device which actuates an aerosol generating means in different modes simultaneously. With the inhalation therapy device according to the invention it is possible to generate specific aerosols relative to the predominant aspect of the therapy. The changeover between different aerosols is to be accomplished without any major effort by the patient and/or the therapist carrying out the treatment.